BREAKING
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 3 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 4 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 5 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 3 days ago Zoom Communications Q4 2025 Earnings Results 4 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 4 days ago Synopsys Q1 2026 Earnings Results 4 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 4 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 4 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 5 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 3 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 4 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 5 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 3 days ago Zoom Communications Q4 2025 Earnings Results 4 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 4 days ago Synopsys Q1 2026 Earnings Results 4 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 4 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 4 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 5 days ago
ADVERTISEMENT
Market News

Thermo Fisher Scientific (TMO): Q3 2019 Earnings Snapshot

— Thermo Fisher Scientific (NYSE: TMO) reported third-quarter 2019 earnings of $2.94 per share, vs. $2.87 per share expected. — Revenues grew 6% to $6.27 billion, vs. $6.18 billion expected. — Raised FY19 revenue guidance to $25.34 – $25.50 billion vs. prior guidance of $25.30 – $25.50 billion. — Adjusted EPS guidance for FY19 raised […]

$TMO October 23, 2019 1 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results
NYSE
$TMO · Earnings

— Thermo Fisher Scientific (NYSE: TMO) reported third-quarter 2019 earnings of $2.94 per share, vs. $2.87 per share expected. — Revenues grew 6% to $6.27 billion, vs. $6.18 billion expected. — Raised FY19 revenue guidance to $25.34 – $25.50 billion vs. prior guidance of $25.30 – $25.50 billion. — Adjusted EPS guidance for FY19 raised […]

· October 23, 2019

Earnings Update by AlphaStreet

— Thermo Fisher Scientific (NYSE: TMO) reported third-quarter 2019 earnings of $2.94 per share, vs. $2.87 per share expected.

— Revenues grew 6% to $6.27 billion, vs. $6.18 billion expected.

— Raised FY19 revenue guidance to $25.34 – $25.50 billion vs. prior guidance of $25.30 – $25.50 billion.

— Adjusted EPS guidance for FY19 raised to a new range of $12.28 – $12.34, vs. earlier guidance of $12.16 – $12.26.

ADVERTISEMENT

— TMO shares have gained 28% since the beginning of this year.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT